IP Library Granted Patent US 9,161,802
Granted Patent B2
US 9,161,802 · App. 13/733,642 · Granted Oct 20, 2015

Patterned electrodes for tissue treatment systems

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,161,802
App. No.
13/733,642
Granted
Oct 20, 2015
Kind
B2
Abstract

Methods, apparatus, and systems for treating tissue located beneath a tissue surface with electromagnetic energy delivered from a treatment electrode. The treatment electrode may include a conductive layer and a plurality of openings extending through the conductive layer. The openings may vary in size or area across the conductive layer, and may vary progressively in size or area with location relative to the electrode perimeter.

Claims (33)

1. A treatment apparatus comprising:

a treatment tip including a treatment electrode and a dielectric layer, the treatment electrode comprising a conductive layer with an outer perimeter, a plurality of first openings extending through the conductive layer, and a plurality of second openings extending through the conductive layer, and the first openings being smaller in size than the second openings, wherein the second openings are located between the outer perimeter and the first openings, and wherein the second openings increase in size closer to the outer perimeter, wherein the conductive layer is in contact with the dielectric layer, and the conductive layer includes a conductive island inside at least some of the second openings, with the conductive islands increasing in size closer to the outer perimeter such that for each of the second openings including a conductive island, a constant ratio of conductive surface area to dielectric opening surface area is maintained;

a handpiece configured to removably receive the treatment tip; and

a generator configured to generate electromagnetic energy, wherein the conductive layer of the treatment electrode is electrically connected with the generator.

2. The apparatus of claim 1 wherein each conductive island is separated by a gap in the conductive layer from an adjacent portion of the conductive layer surrounding a corresponding one of the second openings and is electrically isolated from the adjacent portion of the conductive layer.

3. The apparatus of claim 1 wherein the first openings are free of conductive islands.

4. The apparatus of claim 1 wherein the treatment electrode includes a plurality of third openings each laterally positioned between the first openings and the second openings, the third openings are larger in size than the first openings, and the third openings are smaller in size than the second openings.

5. The apparatus of claim 1 wherein the treatment electrode includes a solid central region, and the first openings and the second openings are laterally positioned between the solid central region and the outer perimeter.

6. The treatment apparatus of claim 1 wherein when the treatment tip is placed on tissue to be delivered heat treatment via the electromagnetic energy, the generator and treatment electrode produce a uniform temperature increase in the tissue.

7. A treatment apparatus comprising:

a treatment tip including a treatment electrode and a dielectric layer, the treatment electrode comprising a planar conductive layer with an outer perimeter defining a solid frame, a plurality of first openings extending through the conductive layer, and a plurality of second openings extending through the conductive layer, and the first openings being smaller in size than the second openings, wherein the second openings are located between the outer perimeter and the first openings such that the second openings are not coincident with the first openings, wherein the conductive layer is in contact with the dielectric layer, and the conductive layer includes a conductive island inside one or more of the second openings

a handpiece configured to removably receive the treatment tip; and

a generator configured to generate electromagnetic energy, wherein the conductive layer of the treatment electrode is electrically connected with the generator.

8. The apparatus of claim 7 wherein each conductive island is separated by a gap in the conductive layer from an adjacent portion of the conductive layer surrounding a corresponding one of the second openings and is electrically isolated from the adjacent portion of the conductive layer.

9. The apparatus of claim 7 wherein the treatment electrode includes a solid central region, and the first openings and the second openings are positioned between the solid central region and the outer perimeter.

10. The treatment apparatus of claim 7 wherein when the treatment tip is placed on tissue to be delivered heat treatment via the electromagnetic energy, the generator and treatment electrode produce a uniform temperature increase in the tissue.

11. The treatment apparatus of claim 7 wherein the second openings increase in size closer to the outer perimeter.

12. The apparatus of claim 7 wherein the first openings are free of conductive islands.

13. The apparatus of claim 7 wherein the treatment electrode includes a plurality of third openings each laterally positioned between the first openings and the second openings, the third openings are larger in size than the first openings, and the third openings are smaller in size than the second openings.

14. The apparatus of claim 7 wherein a size of the conductive islands relative to the associated second openings is correlated such that the area of exposed dielectric layer is constant for each of the second openings.

15. A method of operating a tissue treatment apparatus, the method comprising:

moving a handpiece that removably receives a treatment tip of the tissue treatment apparatus proximate to a tissue surface, the treatment tip including a treatment electrode with a dielectric layer;

contacting a surface of the treatment electrode on the treatment tip with the tissue surface, the treatment electrode including a conductive layer with an outer perimeter, a plurality of first openings extending through the conductive layer, and a plurality of second openings extending through the conductive layer, and the first openings being smaller in size than the second openings, wherein the second openings are located between the outer perimeter and the first openings, and wherein the second openings increase in size closer to the outer perimeter, wherein the conductive layer is in contact with the dielectric layer, and the conductive layer includes a conductive island inside at least some of the second openings, with the conductive islands increasing in size closer to the outer perimeter such that for each of the second openings including a conductive island, a constant ratio of conductive surface area to dielectric opening surface area is maintained;

generating electromagnetic energy with a generator that is electrically connected to the conductive layer; and

capacitively transferring the electromagnetic energy from the conductive layer of the treatment electrode to tissue beneath the tissue surface with a local capacitance that depends upon a position of the conductive layer of the treatment electrode relative to the tissue surface, thereby providing heat treatment to the tissue beneath the tissue surface.

16. The method of claim 15 wherein the local capacitance across a surface of the conductive layer decreases closer to the outer perimeter.

17. The method of claim 15 wherein the treatment electrode has a geometrical center, and capacitively transferring the electromagnetic energy from the conductive layer of the treatment electrode to the tissue comprises:

capacitively transferring electromagnetic energy to the tissue proximate to the outer perimeter from a first portion of the conductive layer, which is perforated by the plurality of second openings to have a first amount of conductor per unit area; and

capacitively transferring electromagnetic energy to the tissue proximate to the geometrical center from a second portion of the conductive layer, which is perforated by the plurality of first openings to have a second amount of conductor per unit area smaller than the first amount of conductor per unit area.

18. The method of claim 15 wherein the treatment electrode has a geometrical center, and capacitively transferring the electromagnetic energy from the conductive layer of the treatment electrode through the dielectric layer to the tissue comprises:

capacitively transferring electromagnetic energy to the tissue proximate to the outer perimeter from a portion of the conductive layer perforated with the plurality of second openings; and

capacitively transferring electromagnetic energy to the tissue proximate to the geometrical center from a solid central region of the conductive layer.

19. The method of claim 15 wherein the electromagnetic energy is capacitively transferred from the conductive layer of the treatment electrode through the dielectric layer to the tissue.

Assignments (20)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
Reel/Frame 073654/0242 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
Reel/Frame 073654/0300 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 073637/0001 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
Reel/Frame 073637/0126 →
U.S. PATENT SECURITY AGREEMENT Recorded Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; BAUSCH HEALTH AMERICAS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 071564/0463 →
U.S. PATENT SECURITY AGREEMENT Recorded Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; BAUSCH HEALTH AMERICAS, INC.; SOLTA MEDICAL, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 071566/0200 →
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
SECURITY AGREEMENT (SECOND LIEN) Recorded Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
SECURITY AGREEMENT (FIRST LIEN) Recorded Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
SECURITY INTEREST Recorded Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
SECURITY AGREEMENT Recorded Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
SECURITY INTEREST Recorded Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
SECURITY INTEREST Recorded Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
SECURITY INTEREST Recorded Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
SECURITY INTEREST Recorded Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
SECURITY INTEREST Recorded Jul 19, 2017
From: SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043041/0921 →
SECURITY INTEREST Recorded Jul 18, 2016
From: SOLTA MEDICAL, INC.
To: BARCLAYS BANK PLC
Reel/Frame 039178/0970 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 27, 2014
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: SOLTA MEDICAL, INC.
Reel/Frame 032126/0206 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Nov 19, 2013
From: SOLTA MEDICAL, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 031674/0546 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2013
From: PRZYBYSZEWSKI, PIOTR J.
To: SOLTA MEDICAL, INC.
Reel/Frame 029704/0281 →